Hypo-Fractionated Radiotherapy to the Cavity for Resected Brain Metastases: A UK Series
In this multicentre series of postoperative hypo-fractionated radiotherapy to the surgical cavity following resection of a brain metastasis, we demonstrated good rates of local control, with low risk of LMD and RN. Therefore, this radiotherapy regimen is a reasonable alternative to cavity SRS in patients with large cavity volumes or complete gross total resection within the UK. This should be investigated further within a prospective trial.
Authors
- Rovel Colaco (ORCID: https://orcid.org/0000-0001-7307-3620)
- C.L. Barker
- Susanna Meade (ORCID: https://orcid.org/0000-0002-8283-6148)
- Thomas S Shane
- Paul Sanghera (ORCID: https://orcid.org/0000-0001-6514-0109)
- M. Jameson
- Helen Benghiat (ORCID: https://orcid.org/0000-0003-1476-715X)
- Carol S. Hodgson (ORCID: https://orcid.org/0000-0002-0114-276X)
- Jennifer King (ORCID: https://orcid.org/0000-0001-9756-6702)
Institutions
- Queen Elizabeth Hospital Birmingham (GB)
- Edwards (United Kingdom) (GB)
- The Christie NHS Foundation Trust (GB)
Publication Details
- Journal
- Clinical Oncology
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1016/j.clon.2025.103847
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00